Top 20 Global Chemical Companies by Revenue in 2025

Air Products & Chemicals reported first-fiscal-quarter results for the period ended December 31, 2025. Quarterly sales totaled $3.103 billion, up from $2.932 billion year-on-year. Quarterly operating profit amounted to $735 million, compared with $644 million a year earlier. Net income attributable to the company stood at $678 million, versus $617 million in the prior-year quarter. Crop Science Syngenta Group released its fourth-quarter and full-year 2025 financial results. Group revenue for the quarter reached $7.6 billion, up from $7.5 billion a year earlier. Of this, Syngenta Crop Protection generated $3.9 billion, Adama $1.0 billion, Syngenta Seeds $1.6 billion, and Syngenta Group China $1.8 billion. Group EBITDA for the quarter was $900 million, down from $1.1 billion a year earlier. Full-year group revenue totaled $28.4 billion, slightly down from $28.8 billion in 2024. Full-year group EBITDA amounted to $4.4 billion, up from $3.9 billion a year earlier. Specifically, Syngenta Crop Protection revenue was $13.7 billion; Adama, $4.1 billion; Syngenta Seeds, $4.8 billion; and Syngenta Group China, $8.3 billion. Bayer Group announced its 2025 financial results. Group net sales for the year totaled €45.575 billion (approx. $49.5 billion), down from €46.606 billion in 2024. EBIT for the year was a loss of €1.077 billion, widening from a loss of €71 million in 2024. Net loss attributable to shareholders was €3.62 billion, versus €2.552 billion in 2024. Within this, the Crop Science division recorded full-year net sales of €21.678 billion (approx. $25.4 billion) and an EBIT loss of €2.532 billion. The Pharmaceuticals division posted net sales of €17.834 billion and EBIT of €3.127 billion. The Consumer Health division reported net sales of €5.808 billion and EBIT of €912 million. Corteva, Inc. reported its fourth-quarter and full-year 2025 financial results. Fourth-quarter net sales were $3.91 billion, down from $3.978 billion a year earlier. Net loss attributable to the company for the quarter was $552 million, versus a loss of $41 million in the prior-year quarter. Full-year net sales totaled $17.401 billion, up from $16.908 billion in 2024. Full-year net income was $1.094 billion, up from $907 million in 2024. Fertilizers Nutrien, the Canadian fertilizer giant, reported its fourth-quarter and full-year 2025 financial results. Quarterly sales amounted to $5.34 billion, up from $5.079 billion year-on-year. Net income attributable to shareholders was $571 million, versus $113 million a year earlier. Full-year sales totaled $26.885 billion, up from $25.972 billion in 2024. Full-year net income attributable to shareholders was $2.267 billion, up sharply from $674 million in 2024. Yara International ASA reported its fourth-quarter and full-year 2025 financial results. Fourth-quarter revenue and other income totaled $4.012 billion, up from $3.419 billion a year earlier.

The 'Three-Way Rivalry' in Global Agriculture: Corteva is splitting up, Syngenta is going public, and Bayer is pivoting

In May 2026, the global agricultural technology industry is undergoing a historic 'simultaneous moment'. On May 4, Corteva announced that its seed business would be branded Vylor and listed independently in Q4 — 'split'. On May 6, Syngenta Group released its Q1 financial report: all four business units posted growth; its Hong Kong IPO filing could come as early as June, with potential fundraising reaching $10 billion — 'go public'. On May 8, Bayer signed a strategic alliance with bp to commercialize mustard greens under the 'newgold™' brand for the biofuel market — 'pivot'. Split. Go public. Pivot. Viewed individually, each move reflects a single company’s strategic choice. But placed side-by-side — all occurring within the same week — they point to one overarching issue: the organizational structure of the global agricultural industry is undergoing a once-in-a-century 'fission'. This is not a discussion about 'which stock to buy'. It is a fundamental judgment about where agriculture’s value will reside going forward. I. Three Paths, One Direction Let’s examine the three moves. Corteva’s move: spin-off for arbitrage. Opening Corteva’s 2025 financial report reveals a stark 'scissors effect' between seeds and crop protection: seed business net sales reached $9.9 billion (+4%), with an operating EBITDA margin of 26.6%; crop protection generated $7.5 billion (+2%), but prices fell 2%, and its margin stood at just 18%. Seeds are valuable; crop protection is not — a verdict delivered by real money in the market. The logic behind the spin-off is straightforward: liberate the seed business (Vylor) from the drag of crop protection, enabling it to command a premium valuation as a 'technology platform'. Q1 data validates this rationale: Corteva’s Q1 net sales totaled $4.905 billion (+11%), with operating EBITDA at $1.44 billion (+21%). Where did this growth come from? From 'the advantages of its seed and crop protection technology portfolio' — both segments grew, yet the margin advantage of seeds continues to widen. The spin-off isn’t a sign that 'something is wrong'; rather, it signals that 'the business is so successful it must be priced separately'. Syngenta’s move: integrated listing. Syngenta’s Q1 results were equally impressive: revenue of $6.4 billion (+2%), EBITDA of $1.4 billion (+5%), and a margin improvement to 21.9%, with all four business units posting growth. Crop protection revenue reached $3.5 billion (+3%), with strong 20% growth in China; seeds generated $1.5 billion (+7%), with explosive 60% growth in Latin America; Syngenta Group China posted $1.5 billion (+1%), and after excluding low-margin trading contraction, underlying growth reached 11%; Adama achieved $1.0 billion (+4%), with profits surging 276% year-on-year. Meanwhile, Syngenta’s Hong Kong IPO is imminent: confidential filing could occur as early as June, with a potential valuation of $50 billion and fundraising of $5–10 billion — potentially becoming Hong Kong’s largest IPO of 2026. CICC and Goldman Sachs are joint sponsors. Corteva is 'splitting'; Syngenta is 'integrating'. Why do two industry giants make diametrically opposite choices at the same time and in the same sector? The answer lies in differences in asset composition. Corteva operates only two businesses — seeds and crop protection — and separating them creates greater value than keeping them together. Syngenta operates four: crop protection, seeds, Adama (generic agrochemicals), and Syngenta Group China (a localization platform). Only when combined do they form the narrative of being 'the world’s only fully integrated, end-to-end agricultural solutions provider spanning both developed and emerging markets'.

Corteva Declares Quarterly Dividend of $0.05 Per Share

Oct 23, 2026

Corteva Inc. announced a quarterly common stock dividend of $0.05 per share payable in December 2026. The agrochemical firm also disclosed preferred stock dividends from its subsidiary EIDP, Inc.

Investing.com Canada

Corteva Declares $0.05 Per Share Quarterly Dividend

Investing.com India

2026-04-21

UBS Raises Corteva Price Target to $88, Maintains Neutral Rating

2026-04-22

DuPont de Nemours Inc. Stock Underperforms vs Competitors on Wednesday

2026-04-24

DuPont’s Electronics Spinoff Qnity Prices $4.1B Debt Deal Ahead of November Split

2026-04-24

RBC Adjusts Price Target on DuPont de Nemours to $56 From $60, Maintains Outperform Rating